Current use of baseline medical treatment in chronic rhinosinusitis: Data from the National Chronic Rhinosinusitis Epidemiology Study (CRES)

Current use of baseline medical treatment in chronic rhinosinusitis: Data from the National... KeypointsLong‐term topical therapy is the cornerstone to managing chronic rhinosinusitis (CRS).Current levels of compliance with nasal douching (ND) and intranasal corticosteroids (INCS) are likely to be poor.Clinicians in both primary and secondary care need to work together to encourage good compliance and ensure where possible guidelines are adhered to for best use of healthcare resources.BACKGROUNDChronic rhinosinusitis (CRS) is a common inflammatory disorder of the respiratory tract defined by the presence of either nasal blockage and/or nasal discharge as well as loss of smell and/or facial pain/pressure for 12 weeks or more; this must be corroborated with endoscopic findings (mucopus/polyps) and/or radiological findings (CT scan opacification in sinuses). Chronic rhinosinusitis affects a significant proportion of the adult population with a recent European study suggesting a prevalence of 11% in the UK. Longitudinal data from the Clinical Practice Research Datalink (CPRD) show that 1% these affected adults receive treatment from their GP each year with an average of 4 GP visits, and additionally this includes prescription of multiple medications with 91% receiving an antibiotic prescription. There are no NICE guidelines, and although international guidelines exist, familiarity and uptake of them is not quantified. These guidelines recommend both intranasal corticosteroids (INCS) and http://www.deepdyve.com/assets/images/DeepDyve-Logo-lg.png Clinical Otolaryngology Wiley

Loading next page...
 
/lp/wiley/current-use-of-baseline-medical-treatment-in-chronic-rhinosinusitis-Yh8nGEv8M1
Publisher
Wiley Subscription Services, Inc., A Wiley Company
Copyright
© 2018 John Wiley & Sons Ltd
ISSN
1749-4478
eISSN
1749-4486
D.O.I.
10.1111/coa.13012
Publisher site
See Article on Publisher Site

Abstract

KeypointsLong‐term topical therapy is the cornerstone to managing chronic rhinosinusitis (CRS).Current levels of compliance with nasal douching (ND) and intranasal corticosteroids (INCS) are likely to be poor.Clinicians in both primary and secondary care need to work together to encourage good compliance and ensure where possible guidelines are adhered to for best use of healthcare resources.BACKGROUNDChronic rhinosinusitis (CRS) is a common inflammatory disorder of the respiratory tract defined by the presence of either nasal blockage and/or nasal discharge as well as loss of smell and/or facial pain/pressure for 12 weeks or more; this must be corroborated with endoscopic findings (mucopus/polyps) and/or radiological findings (CT scan opacification in sinuses). Chronic rhinosinusitis affects a significant proportion of the adult population with a recent European study suggesting a prevalence of 11% in the UK. Longitudinal data from the Clinical Practice Research Datalink (CPRD) show that 1% these affected adults receive treatment from their GP each year with an average of 4 GP visits, and additionally this includes prescription of multiple medications with 91% receiving an antibiotic prescription. There are no NICE guidelines, and although international guidelines exist, familiarity and uptake of them is not quantified. These guidelines recommend both intranasal corticosteroids (INCS) and

Journal

Clinical OtolaryngologyWiley

Published: Jan 1, 2018

Keywords: ; ; ; ; ;

References

You’re reading a free preview. Subscribe to read the entire article.


DeepDyve is your
personal research library

It’s your single place to instantly
discover and read the research
that matters to you.

Enjoy affordable access to
over 18 million articles from more than
15,000 peer-reviewed journals.

All for just $49/month

Explore the DeepDyve Library

Search

Query the DeepDyve database, plus search all of PubMed and Google Scholar seamlessly

Organize

Save any article or search result from DeepDyve, PubMed, and Google Scholar... all in one place.

Access

Get unlimited, online access to over 18 million full-text articles from more than 15,000 scientific journals.

Your journals are on DeepDyve

Read from thousands of the leading scholarly journals from SpringerNature, Elsevier, Wiley-Blackwell, Oxford University Press and more.

All the latest content is available, no embargo periods.

See the journals in your area

DeepDyve

Freelancer

DeepDyve

Pro

Price

FREE

$49/month
$360/year

Save searches from
Google Scholar,
PubMed

Create lists to
organize your research

Export lists, citations

Read DeepDyve articles

Abstract access only

Unlimited access to over
18 million full-text articles

Print

20 pages / month

PDF Discount

20% off